Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,852
datasets available to search
ShareScore release 0.7.1
Dataset results
2,852 results for “Hepatocellular carcinoma”
An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT02576509. IPD Sharing: Not stated. Countries: 22. Publications: 4.
RAD001 in Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT00516165. IPD Sharing: NO. Countries: 1. Publications: 1.
c-Met Second-Line Hepatocellular Carcinoma
ClinicalTrials.gov study NCT02115373. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of Tislelizumab Versus Sorafenib in Participants With Unresectable Hepatocellular Carcinoma (HCC)
ClinicalTrials.gov study NCT03412773. IPD Sharing: YES. Countries: 11. Publications: 3.
Study of Palliative Radiotherapy for Symptomatic Hepatocellular Carcinoma and Liver Metastases
ClinicalTrials.gov study NCT02511522. IPD Sharing: NO. Countries: 1. Publications: 1.
Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT03298451. IPD Sharing: Not stated. Countries: 17. Publications: 7.
Axitinib For The Treatment Of Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT01210495. IPD Sharing: YES. Countries: 13. Publications: 1.
A Study of Recombinant Vaccinia Virus Prior to Sorafenib to Treat Unresectable Primary Hepatocellular Carcinoma
ClinicalTrials.gov study NCT01171651. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Participants With Advanced Hepatocellular Carcinoma (HCC) Who Have Not Received Previous Systemic Anticancer Therapy
ClinicalTrials.gov study NCT03755791. IPD Sharing: NO. Countries: 34. Publications: 3.
PI-88 in Hepatocellular Carcinoma After Hepatectomy
ClinicalTrials.gov study NCT00247728. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study of Pembrolizumab (MK-3475) or Placebo Given With Best Supportive Care in Asian Participants With Previously Treated Advanced Hepatocellular Carcinoma (MK-3475-394/KEYNOTE-394)
ClinicalTrials.gov study NCT03062358. IPD Sharing: YES. Countries: 5. Publications: 2.
A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas
ClinicalTrials.gov study NCT00923481. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Study of Dalantercept and Sorafenib in Patients With Advanced Hepatocellular Carcinoma
ClinicalTrials.gov study NCT02024087. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma.
ClinicalTrials.gov study NCT01035229. IPD Sharing: Not stated. Countries: 18. Publications: 2.
A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein
ClinicalTrials.gov study NCT02435433. IPD Sharing: YES. Countries: 20. Publications: 9.
Orantinib In Combination With Transcatheter Arterial Chemoembolization In Patients With Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT01465464. IPD Sharing: Not stated. Countries: 3. Publications: 1.
TACE Combined With Tyrosine Kinase Inhibitors and Tislelizumab in Unresectable Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06232759. IPD Sharing: YES. Countries: 1. Publications: 4.
Effect of Colchicine for the Palliative Management of Hepatocellular Carcinoma
ClinicalTrials.gov study NCT01935700. IPD Sharing: Not stated. Countries: 1. Publications: 1.
STOPPER CHINA:With Tandem Microspheres in the Treatment of Localized Hepatocellular Carcinoma
ClinicalTrials.gov study NCT03113955. IPD Sharing: NO. Countries: 1. Publications: 2.
18F-DCFPyL PET/CT in Hepatocellular Carcinoma
ClinicalTrials.gov study NCT05009979. IPD Sharing: YES. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.